Stephan Brand

Sankt Gallen, SG, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

Journal: Alimentary pharmacology & therapeutics

Published: June 12, 2026

Symptomatic cholecystolithiasis after cholecystectomy

Symptomatic cholecystolithiasis after cholecystectomy

Journal: Praxis

Published: September 29, 2025

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

Journal: Vaccines

Published: May 24, 2025

First Description of Simultaneous Sweet Syndrome and Tracheal Stenosis as Extraintestinal Manifestations in a Patient With Highly Active Ulcerative Colitis.

First Description of Simultaneous Sweet Syndrome and Tracheal Stenosis as Extraintestinal Manifestations in a Patient With Highly Active Ulcerative Colitis.

Journal: ACG case reports journal

Published: January 15, 2025

Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.

Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.

Journal: Alimentary pharmacology & therapeutics

Published: December 09, 2024

Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial.

Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial.

Journal: Nutrients

Published: November 06, 2024

Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply.

Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: November 06, 2024

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

Journal: Vaccines

Published: October 02, 2024

First Description of Upadacitinib as Treatment for Collagenous Colitis with a Concomitant Lymphocytic Disorder of the Upper Gastrointestinal Tract.

First Description of Upadacitinib as Treatment for Collagenous Colitis with a Concomitant Lymphocytic Disorder of the Upper Gastrointestinal Tract.

Journal: Case reports in gastroenterology

Published: September 02, 2024

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics

Published: August 28, 2024

First Description of Sprue-Like Enteropathy due to Azilsartan: A Case Report.

First Description of Sprue-Like Enteropathy due to Azilsartan: A Case Report.

Journal: Case reports in gastroenterology

Published: July 12, 2024

CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites.

CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites.

Journal: Scientific reports

Published: June 16, 2024

Showing 1-12 of 78

Last Updated: 09/26/2026